Molecular characteristics of multifocal invasive mucinous adenocarcinoma of the lung: Report of a rare case

Thorac Cancer. 2017 Nov;8(6):710-713. doi: 10.1111/1759-7714.12495. Epub 2017 Aug 29.

Abstract

Invasive mucinous adenocarcinoma (IMA) is an uncommon entity in the lung, with a poor prognosis. Multifocal IMA of the lung is even more unusual, and there is little experience with effective treatments. Herein, we present a case of multifocal IMA diagnosed in a 36 year-old man by video-assisted thoracoscopic surgery. A right middle lobe and a nodule in the right upper lobe were resected, as were mediastinal lymph nodes, leaving behind an autonomous right lower lobe nodule. To explore the feasibility of molecular treatment, next-generation sequencing of genetic mutations was performed after four cycles of chemotherapy (pemetrexed + cisplatin). Ultimately, a KIAA1468-RET fusion gene was detected at a disproportionate level (~67.3%), indicating that targeted therapy may be efficacious in treating this disease.

Keywords: Invasive mucinous adenocarcinoma; lung cancer; targeted therapy; thoracoscopic.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma, Mucinous / diagnosis
  • Adenocarcinoma, Mucinous / genetics
  • Adenocarcinoma, Mucinous / therapy*
  • Adult
  • Cisplatin / therapeutic use
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / genetics
  • Lung Neoplasms / therapy*
  • Male
  • Neoplasm Proteins / genetics*
  • Oncogene Proteins, Fusion / genetics
  • Pemetrexed / therapeutic use
  • Proto-Oncogene Proteins c-ret / genetics*
  • Sequence Analysis, DNA
  • Thoracic Surgery, Video-Assisted

Substances

  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • Pemetrexed
  • Proto-Oncogene Proteins c-ret
  • RET protein, human
  • Cisplatin